164 related articles for article (PubMed ID: 21039410)
21. NK-1 Antagonists and Itch.
Ständer S; Luger TA
Handb Exp Pharmacol; 2015; 226():237-55. PubMed ID: 25861784
[TBL] [Abstract][Full Text] [Related]
22. Effects of the neurokinin1 receptor antagonist aprepitant on the pharmacokinetics of dexamethasone and methylprednisolone.
McCrea JB; Majumdar AK; Goldberg MR; Iwamoto M; Gargano C; Panebianco DL; Hesney M; Lines CR; Petty KJ; Deutsch PJ; Murphy MG; Gottesdiener KM; Goldwater DR; Blum RA
Clin Pharmacol Ther; 2003 Jul; 74(1):17-24. PubMed ID: 12844131
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of refractory neuropathic pruritus with capsaicin 8% patch: a bicentric retrospective study with long-term follow-up.
Misery L; Erfan N; Castela E; Brenaut E; Lantéri-Minet M; Lacour JP; Passeron T
Acta Derm Venereol; 2015 Sep; 95(7):864-5. PubMed ID: 25740045
[No Abstract] [Full Text] [Related]
24. Pharmacokinetics of aprepitant after single and multiple oral doses in healthy volunteers.
Majumdar AK; Howard L; Goldberg MR; Hickey L; Constanzer M; Rothenberg PL; Crumley TM; Panebianco D; Bradstreet TE; Bergman AJ; Waldman SA; Greenberg HE; Butler K; Knops A; De Lepeleire I; Michiels N; Petty KJ
J Clin Pharmacol; 2006 Mar; 46(3):291-300. PubMed ID: 16490805
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of therapy-resistant pruritus in lichen amyloidosis with menthol.
Frölich M; Enk A; Diepgen TL; Weisshaar E
Acta Derm Venereol; 2009; 89(5):524-6. PubMed ID: 19734984
[No Abstract] [Full Text] [Related]
26. Aprepitant against pruritus in patients with solid tumours.
Vincenzi B; Fratto ME; Santini D; Tonini G
Support Care Cancer; 2010 Sep; 18(9):1229-30. PubMed ID: 20544226
[No Abstract] [Full Text] [Related]
27. Aprepitant: a novel neurokinin-1 receptor/substance P antagonist as antipruritic therapy in cutaneous T-cell lymphoma.
Ladizinski B; Bazakas A; Olsen EA
J Am Acad Dermatol; 2012 Nov; 67(5):e198-9. PubMed ID: 23062910
[No Abstract] [Full Text] [Related]
28. Successful treatment of genital pruritus using topical immunomodulators as a single therapy in multi-morbid patients.
Weisshaar E
Acta Derm Venereol; 2008; 88(2):195-6. PubMed ID: 18311464
[No Abstract] [Full Text] [Related]
29. Capsaicin 8% cutaneous patch: a promising treatment for brachioradial pruritus?
Zeidler C; Lüling H; Dieckhöfer A; Osada N; Schedel F; Steinke S; Augustin M; Ständer S
Br J Dermatol; 2015 Jun; 172(6):1669-1671. PubMed ID: 25354282
[No Abstract] [Full Text] [Related]
30. Ondansetron and pruritus in chronic liver disease: a controlled study.
Jones EA; Molenaar HA; Oosting J
Hepatogastroenterology; 2007 Jun; 54(76):1196-9. PubMed ID: 17629069
[TBL] [Abstract][Full Text] [Related]
31. Does continuous subcutaneous infusion of lignocaine relieve intractable pruritus associated with advanced cutaneous T-cell lymphoma? A retrospective case series review.
Norris J; Barker J; Buelens O; Spruijt O
Palliat Med; 2019 May; 33(5):552-556. PubMed ID: 30712496
[TBL] [Abstract][Full Text] [Related]
32. Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy.
de Wit R; Herrstedt J; Rapoport B; Carides AD; Carides G; Elmer M; Schmidt C; Evans JK; Horgan KJ
J Clin Oncol; 2003 Nov; 21(22):4105-11. PubMed ID: 14559891
[TBL] [Abstract][Full Text] [Related]
33. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
[TBL] [Abstract][Full Text] [Related]
34. The use of aprepitant in brachioradial pruritus.
Ally MS; Gamba CS; Peng DH; Tang JY
JAMA Dermatol; 2013 May; 149(5):627-8. PubMed ID: 23677105
[No Abstract] [Full Text] [Related]
35. [Antipruritic mechanisms of pimecrolimus cream for facial dermatitis in adult women patients].
Xie ZQ; Yang GY; Jiang W; Xu ML
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):27-30. PubMed ID: 19317053
[TBL] [Abstract][Full Text] [Related]
36. Itch Management: Treatments under Development.
Pereira MP; Ständer S
Curr Probl Dermatol; 2016; 50():71-6. PubMed ID: 27578074
[TBL] [Abstract][Full Text] [Related]
37. Serum soluble interleukin 2 receptor levels in erythrodermic cutaneous T-cell lymphoma correlate with response to photopheresis-based treatment.
Goldman BD; Oh SK; Davis BE; Kadin ME; Poiesz BJ; Koh HK
Arch Dermatol; 1993 Sep; 129(9):1166-70. PubMed ID: 8363402
[TBL] [Abstract][Full Text] [Related]
38. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
[TBL] [Abstract][Full Text] [Related]
39. The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case.
Chang Y; Golkar L
Pediatr Dermatol; 2008; 25(3):403-4. PubMed ID: 18577062
[TBL] [Abstract][Full Text] [Related]
40. Brachioradial pruritus: Mayo Clinic experience over the past decade.
Mirzoyev SA; Davis MD
Br J Dermatol; 2013 Nov; 169(5):1007-15. PubMed ID: 23796379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
